PDMR Shareholding

Summary by AI BETAClose X

Acceler8 Ventures plc announced that Daniel Levine, the Chief Executive Officer, purchased 165,500 ordinary shares between 57.5 pence and 62.5 pence, and Giles Willits, the Chief Financial Officer, purchased 75,500 ordinary shares at 62.5 pence. Following these transactions, Daniel Levine now beneficially holds approximately 6.7% of the company's issued share capital, and Giles Willits holds approximately 2.46%. These purchases by key management personnel may be viewed positively by investors as a sign of confidence in the company's future prospects.

Disclaimer*

Acceler8 Ventures PLC
15 October 2026
 

Ventures

AI-generated content may be incorrect.

Acceler8 Ventures plc

("AC8" or the "Company")

PDMR Shareholding

AC8 announces that it has been notified that on 13 and 14 October 2026, Daniel Levine and Giles Willits, each a Person Discharging Managerial Responsibilities ("PDMR") of the Company, purchased ordinary shares in the Company on the open market, as follows:

PDMR

Position

Number of shares purchased

Price per share

Daniel Levine

Chief Executive Officer

165,500

Between 57.5 pence and 62.5 pence

Giles Willits

Chief Financial Officer

75,500

62.5 pence

 

Following these purchases:

  • Daniel Levine is beneficially interested in 50,846,424 ordinary shares, representing approximately 6.7% of the Company's issued ordinary share capital; and
  • Giles Willits is beneficially interested in 18,656,154 ordinary shares, representing approximately 2.46% of the Company's issued ordinary share capital.

The notifications below, made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation, provide further details.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1. Details of the person discharging managerial responsibilities / person closely associated

 

a) Name

Daniel Levine

2. Reason for the notification

 

a) Position/status

Chief Executive Officer

b) Initial notification / Amendment

Initial notification

3. Details of the issuer

 

a) Name

Acceler8 Ventures plc

b) LEI

2138004B1HKZP1OR2C72

4. Details of the transaction(s)

 

a) Description of the financial instrument, type of instrument

Ordinary shares

Identification code

JE00BNG2DL20

b) Nature of the transaction

Purchase of ordinary shares

c) Price(s) and volume(s)

Price(s)

Volume(s)

£0.575

70,000

£0.60

10,000

d) Aggregated information

 

Aggregated volume: 80,000 Aggregated price: 57.81p per share

 

e) Date of the transaction

13 October 2026

f) Place of the transaction

London Stock Exchange (XLON)

 

 

 

1. Details of the person discharging managerial responsibilities / person closely associated

 

a) Name

Daniel Levine

2. Reason for the notification

 

a) Position/status

Chief Executive Officer

b) Initial notification / Amendment

Initial notification

3. Details of the issuer

 

a) Name

Acceler8 Ventures plc

b) LEI

2138004B1HKZP1OR2C72

4. Details of the transaction(s)

 

a) Description of the financial instrument, type of instrument

Ordinary shares

Identification code

JE00BNG2DL20

b) Nature of the transaction

Purchase of ordinary shares

c) Price(s) and volume(s)

Price(s)

Volume(s)

£0.625

7,800

£0.625

77,700

d) Aggregated information

Aggregated volume: 85,500 Aggregated price: 62.5p per share

e) Date of the transaction

14 October 2026

f) Place of the transaction

London Stock Exchange (XLON)

 

 

 

1. Details of the person discharging managerial responsibilities / person closely associated

 

a) Name

Giles Willits

2. Reason for the notification

 

a) Position/status

Chief Financial Officer

b) Initial notification / Amendment

Initial notification

3. Details of the issuer

 

a) Name

Acceler8 Ventures plc

b) LEI

2138004B1HKZP1OR2C72

4. Details of the transaction(s)

 

  1.        Description of the financial instrument, type

of instrument

Ordinary shares

Identification code

JE00BNG2DL20

b) Nature of the transaction

Purchase of ordinary shares

c) Price(s) and volume(s)

Price: 62.5p per share Volume: 75,500

d) Aggregated information

Aggregated volume: 75,500 Aggregated price: 62.5p per share

e) Date of the transaction

14 October 2026

f) Place of the transaction

London Stock Exchange (XLON)

 

Enquiries:

Acceler8 Ventures Plc

 

Daniel Levine

Giles Willits

 

C/o FTI Consulting

Joh. Berenberg, Gossler & Co. KG, London Branch

 

Matthew Armitt

Mark Whitmore

Alex Wright

 

+44 (0)20 3207 7800

FTI Consulting

 

John Waples

Valerija Cymbal

Jemima Gurney

+44 (0)20 3727 1000

AC8@fticonsulting.com

 

About Accelr8 Ventures Plc

AC8 plc is a main market public listed company focused on driving shareholder value through creating and developing technology enabled business opportunities.

About Hui10

AC8's principal operating business is Hui10 Inc. Hui10 is a Beijing-headquartered technology group that has spent more than a decade developing digital infrastructure creating a new digital engagement and transaction layer within China's regulated lottery ecosystem, including AI-enabled tools and Big Data capabilities. Its technology enables transactional activity that connects with consumers and merchants, supporting improved oversight, engagement, transaction traceability and operational insight. With deep integration into national payment infrastructure, UnionPay certified point-of-sale technology, together with established commercial relationships with regulated financial technology service providers and institutions. Hui10 has developed a differentiated and strategically important position from which to continue the digital evolution of its platform and services.

Hui10 aims to increase lottery participation through expanding consumer access throughout China, enhancing the customer experience through building new digital enabled products and services, and enabling its Lucky World retail brand across the existing lottery shop network.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100